Insiders Xenon Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
42.73 ^USD	+5.51%		+3.99%	-7.23%

Apr. 19	Xenon Pharmaceuticals Inc. Announces Board Resignations	CI
Mar. 11	Transcript : Xenon Pharmaceuticals Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-11-2024 11:20 AM

Xenon Pharmaceuticals Inc. Announces Board Resignations	Apr. 19	CI
Xenon Pharmaceuticals Insider Sold Shares Worth $330,290, According to a Recent SEC Filing	Mar. 08	MT
Xenon Pharmaceuticals Insider Sold Shares Worth $601,615, According to a Recent SEC Filing	Mar. 08	MT
Xenon Pharmaceuticals Insider Sold Shares Worth $758,983, According to a Recent SEC Filing	Dec. 15	MT
Insider Sell: Xenon Pharmaceuticals	23-08-24	MT
Xenon Pharmaceuticals Inc. Announces Board Appointments	23-08-08	CI
Insider Sell: Xenon Pharmaceuticals	23-05-30	MT
Xenon Pharmaceuticals Inc. Announces Appointment of Andrea Difabio as Chief Legal Officer and Corporate Secretary	22-11-07	CI
Insider Sell: Xenon Pharmaceuticals	22-09-07	MT
Insider Sell: Xenon Pharmaceuticals	22-09-02	MT
Insider Sell: Xenon Pharmaceuticals	22-08-16	MT
Insider Sell: Xenon Pharmaceuticals	22-08-16	MT
Xenon Pharmaceuticals Inc. Announces Michael Hayden Will Not Stand for Re-Election as Member of Board	22-06-01	CI
Insider Sell: Xenon Pharmaceuticals	22-03-09	MT
Insider Sell: Xenon Pharmaceuticals	22-03-09	MT
Insider Sell: Xenon Pharmaceuticals	22-03-09	MT
Xenon Pharmaceuticals Inc. Appoints Christopher Kenney, M.D. as Chief Medical Officer	21-08-23	CI
Xenon Pharmaceuticals Inc. Announces Board Appointments	21-06-03	CI
Xenon Pharmaceuticals Inc Elects Ian Mortimer as Chief Executive Officer	21-06-03	CI
Insider Trends: Xenon Pharmaceuticals Insider Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact	21-06-01	MT

No results for this search